TQC3564

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQC3564, covering 2024-11-26 to 2024-11-26. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Efficacy and Safety of TQC3564 Tablets in the Treatment of Persistent Allergic Rhinitis [Phase 1]